Related Experiment Video
Updated: Dec 26, 2025
07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
710
Interventional Therapies in Acute Pulmonary Embolism
Robert Zhang1, Taisei Kobayashi1, Steven Pugliese1
1Hospital of the University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA.
Interventional Cardiology Clinics
|March 10, 2020
Summary
Acute pulmonary embolism (PE) treatment now includes advanced catheter interventions like thrombolysis and embolectomy, offering alternatives to systemic thrombolysis with potentially lower bleeding risks. A multidisciplinary PE response team aids in treatment decisions for intermediate to high-risk patients.
Area of Science:
- Cardiovascular Medicine
- Interventional Pulmonology
- Medical Technology
Background:
- Traditional acute pulmonary embolism (PE) management relies on anticoagulation and systemic thrombolytic therapy.
- Systemic thrombolysis carries significant bleeding risks, particularly in intermediate to high-risk PE patients.
- Emerging catheter-based interventions aim to improve treatment efficacy and safety for acute PE.
Purpose of the Study:
- To review the evolving treatment landscape for acute pulmonary embolism (PE).
- To compare catheter-directed interventions with traditional therapies for PE.
- To highlight the role of multidisciplinary teams in managing complex PE cases.
Main Methods:
- Overview of current treatment modalities for acute pulmonary embolism (PE).
- Discussion of catheter-directed thrombolysis and catheter-based embolectomy as advanced interventions.
- Emphasis on the decision-making process involving multidisciplinary PE response teams.
Main Results:
- Catheter-based interventions show promise in reducing bleeding complications compared to systemic thrombolysis.
- Both catheter-directed thrombolysis and embolectomy are active areas of research with distinct risk-benefit profiles.
- Multidisciplinary collaboration is crucial for optimizing treatment selection in acute PE.
Conclusions:
- Catheter-guided interventions represent a significant advancement in acute pulmonary embolism (PE) management.
- Further research is ongoing to define the optimal role and techniques for these advanced therapies.
- A coordinated, multidisciplinary approach is essential for effective treatment of intermediate to high-risk PE.
Related Concept Videos
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
213
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
213
01:27Pulmonary Embolism III: Nursing Management
254
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
254
01:29Venous Thrombosis III: Interprofessional Care
222
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
222
01:29Pulmonary Embolism I: Introduction
423
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
423
01:27Peripheral Artery Disease III: Interprofessional Care
186
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
186
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
384
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
384